SCHEMBL6370549

SCHEMBL6370549

c1ccc(-c2n[nH]c3cc(Nc4ccccn4)ccc23)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 7/20 0.70
MAPK14 Q16539 6/20 0.70
MAPK8 P45983 5/20 0.61
MAP2K4 P45985 1/20 0.51
AXL P30530 1/20 0.50
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
ALPL P05186 1/20 0.47
GAA P10253 1/20 0.47
IDO1 P14902 1/20 0.47
HPGD P15428 1/20 0.47
TTK P33981 1/20 0.47
GRM4 Q14833 2/20 0.47
LRRK2 Q5S007 1/20 0.46
DCLK1 O15075 1/20 0.44
PRKD3 O94806 1/20 0.44
MAP4K4 O95819 1/20 0.44
CHEK2 O96017 1/20 0.44
CSF1R P07333 1/20 0.44
FER P16591 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6370576 0.99 MAPK10 (0.68) MAPK10MAPK14MAPK8MAP2K4AXL
SCHEMBL31060683 0.83 MAPK10 (1.00) MAPK10MAPK14MAPK8MAP2K4AXL
SCHEMBL6582340 0.83 MAPK10 (1.00) MAPK10MAPK14MAPK8MAP2K4AXL
Hydrochloric Acid SCHEMBL6369462 0.81 MAPK10 (0.97) MAPK10MAPK14MAPK8MAP2K4AXL
Hydrochloric Acid SCHEMBL6370716 0.77 MAPK10 (0.81) MAPK10MAPK14MAPK8MAP2K4AXL
Hydrochloric Acid SCHEMBL6371107 0.76 MAPK10 (0.75) MAPK10MAPK14MAPK8MAP2K4AXL
Hydrochloric Acid SCHEMBL6370086 0.76 MAPK10 (0.70) MAPK10MAPK14MAPK8MAP2K4AXL
Hydrochloric Acid SCHEMBL6375849 0.75 MAPK10 (0.70) MAPK10MAPK14MAPK8MAP2K4AXL
Hydrochloric Acid SCHEMBL6370463 0.75 MAPK10 (0.97) MAPK10MAPK14MAPK8MAP2K4AXL
Hydrochloric Acid SCHEMBL6370649 0.74 MAPK10 (0.75) MAPK10MAPK14MAPK8MAP2K4AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113370-A1 Therapeutic substituted indazole derivatives ASTRAZENECA AB (SE) 2005-05-26 US disclosed
EP-1476432-A1 THERAPEUTIC SUBSTITUTED INDAZOLE DERIVATIVES AstraZeneca AB (SE) 2004-11-17 EP disclosed
WO-2003068754-A1 THERAPEUTIC SUBSTITUTED INDAZOLE DERIVATIVES ASTRAZENECA AB (SE) 2003-08-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113370-A1 Therapeutic substituted indazole derivatives NR4A3, CBR3, NR3C2 MAPK10 2059/4885MAPK14 2226/4885MAPK8 1582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.